Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges

Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges

Abstract Background The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has caused a deadly pandemic in the 21st century, resulting in many deaths, economic loss, and international immobility. Vaccination represents the only mechanism to defeat this virus. Several intramuscular vaccines...

Full description

Bibliographic Details
Main Authors: Sanchita Kar, Popy Devnath, Talha B. Emran, Trina E. Tallei, Saikat Mitra, Kuldeep Dhama
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:Immunity, Inflammation and Disease
Subjects:
COVID‐19
intranasal vaccines
mass vaccination
mucosal vaccines
oral vaccines
SARS‐CoV‐2
Online Access:https://doi.org/10.1002/iid3.604

Internet

https://doi.org/10.1002/iid3.604

Similar Items